Eam Investors, LLC Evolus, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$10.22 - $13.94 $1.05 Million - $1.43 Million	102,752 Added 33.96%	405,341 $4.7 Million
Q1 2022 May 13, 2022	BUY	$5.22 - $11.78 $1.58 Million - $3.56 Million	302,589 New	302,589 $3.4 Million
Q2 2019 Aug 14, 2019	SELL	$13.19 - $28.36 $1.17 Million - $2.51 Million	-88,615 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$12.43 - $28.91 $1.1 Million - $2.56 Million	88,615 New	88,615 $2 Million

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.